Jafari Narjes, Abediankenari Saeid
Immunogenetics Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
BMC Immunol. 2024 Dec 20;25(1):84. doi: 10.1186/s12865-024-00675-3.
Epithelial cells (ECs) provide the first line of defense against microbial threats and environmental challenges. They participate in the host's immune responses via the expression and secretion of various immune-related molecules such as cytokines and chemokines, as well as interaction with immune cells. A growing body of evidence suggests that the dysregulated function of ECs can be involved in the pathophysiology of a broad range of infectious, autoimmune, and inflammatory diseases, including inflammatory bowel disease (IBD), asthma, multiple sclerosis, and rheumatoid arthritis. To maintain a substantial immunoregulatory function of ECs, precise expression of different molecules and their regulatory effects are indispensable. MicroRNAs (miRNAs, miRs) are small non-coding RNAs that regulate gene expression commonly at post-transcriptional level through degradation of target messenger RNAs (mRNAs) or suppression of protein translation. MiRNAs implicate as critical regulators in many cellular processes, including apoptosis, growth, differentiation, and immune response. Due to the crucial roles of miRNAs in such a vast range of biological processes, they have become the spotlight of biological research for more than two decades, but we are still at the beginning stages of the use of miRNA-based therapies in the improvement of human health. Hence, in the present paper, attempts are made to provide a comprehensive overview with regard to the roles of miRNAs in the immunoregulatory functions of ECs. A better understanding of the molecular mechanisms through which immunoregulatory properties of ECs are manifested, could aid the development of efficient strategies to prevent and treat multiple human diseases.
上皮细胞(ECs)是抵御微生物威胁和环境挑战的第一道防线。它们通过表达和分泌细胞因子、趋化因子等各种免疫相关分子以及与免疫细胞相互作用,参与宿主的免疫反应。越来越多的证据表明,ECs功能失调可能参与多种感染性、自身免疫性和炎症性疾病的病理生理过程,包括炎症性肠病(IBD)、哮喘、多发性硬化症和类风湿性关节炎。为维持ECs强大的免疫调节功能,不同分子的精确表达及其调节作用必不可少。微小RNA(miRNA,miR)是一类小的非编码RNA,通常在转录后水平通过降解靶信使RNA(mRNA)或抑制蛋白质翻译来调节基因表达。miRNA在许多细胞过程中作为关键调节因子发挥作用,包括细胞凋亡、生长、分化和免疫反应。由于miRNA在如此广泛的生物学过程中发挥关键作用,二十多年来它们一直是生物学研究的焦点,但我们在基于miRNA的疗法改善人类健康方面仍处于起步阶段。因此,在本文中,我们试图全面概述miRNA在ECs免疫调节功能中的作用。更好地理解ECs免疫调节特性的分子机制,有助于制定预防和治疗多种人类疾病的有效策略。